Digirad (NASDAQ:DRAD) Stock Rating Upgraded by ValuEngine

Digirad (NASDAQ:DRAD) was upgraded by stock analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued on Thursday, June 6th, ValuEngine reports.

Shares of Digirad stock traded down $0.20 during trading on Thursday, hitting $6.71. 10,680 shares of the stock were exchanged, compared to its average volume of 11,597. Digirad has a 1-year low of $4.20 and a 1-year high of $19.50. The stock has a fifty day moving average of $3.59. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.59 and a quick ratio of 1.18.

Digirad (NASDAQ:DRAD) last announced its quarterly earnings results on Friday, May 3rd. The medical equipment provider reported ($0.50) EPS for the quarter. The company had revenue of $23.91 million during the quarter. Digirad had a negative net margin of 4.90% and a negative return on equity of 9.16%.

In other Digirad news, Director Jeffrey E. Eberwein purchased 85,000 shares of the firm’s stock in a transaction on Wednesday, May 8th. The stock was purchased at an average cost of $0.66 per share, for a total transaction of $56,100.00. Following the transaction, the director now owns 644,152 shares in the company, valued at approximately $425,140.32. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Over the last 90 days, insiders acquired 158,538 shares of company stock valued at $103,800. Corporate insiders own 7.30% of the company’s stock.

A hedge fund recently bought a new stake in Digirad stock. Weber Alan W purchased a new stake in Digirad Co. (NASDAQ:DRAD) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 100,000 shares of the medical equipment provider’s stock, valued at approximately $91,000. Weber Alan W owned about 0.49% of Digirad as of its most recent filing with the Securities and Exchange Commission.

About Digirad

Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through three segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services.

See Also: What is a management fee?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Digirad Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad and related companies with MarketBeat.com's FREE daily email newsletter.